A DNA vector encoding an infectious RNA molecule initiates live attenuated chikungunya virus production in host tissues.
Indicator fluids trace molecular movement within the cranio-spinal cavity to quantify substance clearance rates.
A water-soluble 18F-labeled prosthetic group enables rapid bioorthogonal click reactions for biomolecule labeling under mild aqueous conditions.
Fluorescent probe clearance measurement replaces invasive urine collection, resolving the trade-off between GFR accuracy and treatment timing delays in CRRT.
Segmented human coding exons replace mouse sequences to align RNA expression levels with human physiology, resolving low similarity bottlenecks.
Replacing invasive biopsies, this agent enables noninvasive detection of secondary mutations and monitoring of treatment resistance.
Immature seed extracts induce desensitization via protein denaturation, reducing adverse reactions and wheal size in allergic children.